TMOD-02. IN VITRO & IN VIVO CULTURE OF PATIENT DERIVED (PD) CSF-CTCS IN LEPTOMENINGEAL DISEASE (LMD) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES

BACKGROUND: Approx. 5% of melanoma pts develop LMD. There are essentially no models of LMD available for therapeutic development. A significant barrier to the development of effective therapies against LMD has been the inability to culture and expand LMD cells. Here we report our strategies to in vi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Law, Vincent, Evernden, Brittany, Puskas, John, Caceres, Gisela, Ryzhova, Elena, Smalley, Inna, Tran, Nam, Etame, Arnold, Magliocco, Anthony, Smalley, Keiran, Forsyth, Peter
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Tumor Models
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651062/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.953
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items